Under the warm sun and surrounded by palm trees, clinical leaders from around the world reunited at SCOPE 2023 and met with Morningside about Life Science Translations. From Feb 6-9, the 14th year of SCOPE brought together over 2,300 leaders in clinical operations and research to Orlando, Florida, at the Rosen Shingle Creek, where programs focused on advances and innovative solutions in clinical trials, planning, management, and operations.
The SCOPE of it
Our experienced Morningside Life Science translations team had the opportunity to reconnect with old partners and meet with many new faces this year at SCOPE. It was refreshing to talk with everyone face-to-face, learn about clinical operations and research teams’ challenges, and better understand your needs.
Bringing a drug to market can be long and costly, from discovery to delivery. Translations are required at various product lifecycle stages, including clinical research, regulatory submissions, labeling, and marketing & commercialization. We know how costly translation errors can be, which may lead to delays in time-to-market, so our rigorous quality controls are certified to the latest ISO 9001, 13485, and 17100 standards.
We had the chance to introduce attendees to the extensive language expertise we provide and how we can help alleviate your pains with services such as;
- Clinical Translation and Validation – Elevate your standards of accuracy and achieve better outcomes.
- Regulatory Translation – Meet local regulatory requirements and gain swift approval from the EMA, FDA, CFDA and PMDA.
- Medical Interpretation – Reduce the risk of miscommunication with specialized medical interpretation
- Marketing and Commercialization – Make your go-to-market plan a success with culturally relevant promotional and educational materials.
- Intellectual Property – Gain international protection for your IP with cost-effective patent translation and foreign filing services.
We equip the world’s leading life sciences organizations with a full suite of end-to-end language solutions for regulatory, clinical, commercial and patent needs. With over 4,000 clients in 55 countries, we’re globally recognized for our life science expertise and technology innovation across pharma, biotech, medical devices, and healthcare. Our life sciences translation services ensure your products and ideas can seamlessly reach new markets and comply with all regulatory and cultural requirements through every stage of the product lifecycle — from patent to post-market.
While at SCOPE we helped advise on how our translations done by subject matter experts help save time and money on your translation needs and help you reach your goals. Quality is at the heart of what we do and our primary focus. Our commitment to quality spans every stage of the project lifecycle, from initial request through on-time delivery. It’s why we’re trusted by leading organizations to translate over 400 million words a year and file over 18,000 patents around the globe.
Our Quality Management System (QMS) is certified to the latest ISO 9001, 13485, and 17100 standards, and is independently audited to ensure compliance. Over the past 20 years, we have worked tirelessly and continuously to improve our processes – from the rigorous vetting and onboarding of translators and subject matter experts to our proprietary Quality Reliability Indicator (QRI) algorithm and post-production audits. Each process includes built-in redundancies and is supported by industry-leading technology to mitigate risk and ensure error-free deliverables.
Whether you are facing issues getting your ICF, CRF, or Patient Recruitment materials translated into your targeted languages or finding interpreters to assist in adverse severe event calls, we spent significant time informing clinical operations teams and researchers that they could rely on Morningside to equip themselves to overcome any language challenges they face.
We want to reassure you that you can trust in the quality of our translations, knowing Morningside is ISO 9001:2015, 13485:2016, and 7100:2015 certified, ensuring high-quality translations every time!
If you want more Life Science Translations after SCOPE 2023:
If you didn’t get a chance to stop by our booth to learn about our language solutions, our experts are still available for consultations. If you did get to stop by to speak with our Morningside experts, we know you walked away with the information you need to help solve your business’ language solution needs. Contact us today for your language service needs.
About Morningside
Morningside, a Questel Company, provides reliable pharmaceutical translation services for every stage of the product lifecycle. In the discovery stage, drug and biotech companies rely on us to help patent and protect their ideas abroad. Sponsors and CROs partner with Morningside during the clinical stage to plan their budgets, translate their documentation and validate their COAs. In preparation for regulatory approval, we provide translation services for a range of regulatory documentation from labeling, packaging, and IFUs, to EC/IRB Correspondence, NDAs and INDs. Finally, when it is time to enter foreign markets, we localize and culturally adapt marketing materials, websites, eIFUs and eLearning modules. To round out the product lifecycle, we provide translations for post-market adverse event reporting.
Bryan Sulicki, Life Science Business Development Associate at Morningside, a Questel Company, is responsible for supporting the company’s life science translation goals and maintaining strong relationships with leading pharmaceutical and medical device companies. Bryan advises life science organizations on best translation practices with workflows that cut cost, boost quality, and reduce time. He strongly focuses on global marketing, regulatory, and clinical documentation that ensures compliance in the pharmaceutical and medical device marketplaces.